The resource you are trying to access is only available for registered users. To continue please login or create an account for free
  • Difficult

Continued prophylactic anticoagulation after hospitalisation for a medical condition

In patients hospitalised for an acute medical condition who also have an increased risk of venous thromboembolism (VTE), continued thromboprophylaxis with rivaroxaban (10 mg/day) for 45 days after discharge from hospital is associated, as compared to a placebo, with a risk of symptomatic or fatal VTE that is: